Next generation PET imaging agent identifies 100% of malignant breast cancer tumors in clinical trial and displays potential to replace many invasive biopsy procedures.
(PRWeb March 13, 2013)
Read the full story at http://www.prweb.com/releases/2013/3/prweb10520654.htm